ARTICLE | Clinical News
Prosorba column data
October 30, 1995 8:00 AM UTC
The Seattle company presented data from 15 patients, who had 59 percent reduction in painful joints and 60 percent reduction in swollen joints at the six-month follow-up, three months after the last treatment.
Nine patients had a positive clinical response under the Paulus criteria (see AIMM item above) at four months, 10 patients at five months, and 7 patients at six months. ...